MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ALKS made $392,911K in revenue. -$67,288K in net income. Net profit margin of -17.13%.

Income Overview

Revenue
$392,911K
Net Income
-$67,288K
Net Profit Margin
-17.13%
EPS
-$0.4
Unit: Thousand (K) dollars
Revenue Breakdown
    • Vivitrol
    • Aristada And Aristada Initio
    • LYBALVI
    • Others

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenues
392,911 384,547 394,185 390,657
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)
61,578 46,209 51,591 49,460
Research and development
103,345 93,038 81,739 77,370
Net income from continuing operations
-49,341 82,761 87,098
Discontinued operations, net of tax
--0 0
Total revenues-Research And Development
--0 -
Selling, general and administrative
264,593 187,196 171,773 170,849
Amortization of acquired intangible assets
11,675 -0 0
Total expenses
441,191 326,443 305,103 297,679
Operating (loss) income
-48,280 58,104 89,082 92,978
Other income, net
---771
Interest income
8,539 12,130 11,943 11,090
Interest expense
20,892 12,410* 0 0
Other (expense) income, net
-1,293 2,553* -280 -
Total other (expense) income, net
-13,646 2,273 11,663 11,861
(loss) income before income taxes
-61,926 60,377 100,745 104,839
Income tax provision
4,554 11,036 17,984 17,741
Net (loss) income
-66,480 49,341 82,761 87,098
Holding (loss) gain, net of a tax (benefit) provision of (171), and 168, respectively
-568 -1,041 341 55
Foreign currency translation loss
-240 ---
Comprehensive (loss) income
-67,288 48,300 83,102 87,153
Basic EPS
-0.4 0.292 0.5 0.53
Diluted EPS
-0.4 0.285 0.49 0.52
Basic Average Shares
166,196,000 165,360,000 165,086,000 164,959,000
Diluted Average Shares
166,196,000 169,368,000 168,510,000 168,357,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive (loss) income-$67,288K (-392.86%↓ Y/Y)Net (loss) income-$66,480K (-395.94%↓ Y/Y)Holding (loss) gain, netof a tax (benefit)...-$568K (-210.94%↓ Y/Y)Foreign currencytranslation loss-$240K Vivitrol$112,434K Aristada And AristadaInitio$93,824K LYBALVI$92,364K LUMRYZ$39,492K Royalty$50,729K Manufacturing Revenue$4,068K (loss) income beforeincome taxes-$61,926K (-342.95%↓ Y/Y)Income tax provision$4,554K (50.55%↑ Y/Y)Product$338,114K Manufactured Product AndRoyalty$54,797K Operating (loss) income-$48,280K (-450.06%↓ Y/Y)Total other (expense)income, net-$13,646K (-216.66%↓ Y/Y)Total revenues$392,911K (28.19%↑ Y/Y)Interest income$8,539K (-15.80%↓ Y/Y)Total expenses$441,191K (50.72%↑ Y/Y)Interest expense$20,892K Other (expense)income, net-$1,293K (-183.10%↓ Y/Y)Selling, general andadministrative$264,593K (54.10%↑ Y/Y)Research and development$103,345K (43.90%↑ Y/Y)Cost of goodsmanufactured and sold...$61,578K (25.17%↑ Y/Y)Amortization of acquiredintangible assets$11,675K

Alkermes plc. (ALKS)

Alkermes plc. (ALKS)